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Abstract
Background: Open reading frame 58 (ORF58) of varicella-zoster virus (VZV) lies at the 3'end of
the Unique long (UL) region and its functional is unknown. In order to clarify whether ORF58 is
essential for the growth of VZV, we constructed a deletion mutant of ORF58 (pOka-BAC∆58)
from the Oka parental genome cloned into a bacterial artificial chromosome (pOka-BAC).
Results:  The ORF58-deleted virus (rpOka∆58) was reconstituted from the pOka-BAC∆58
genome in MRC-5 cells, indicating that the ORF58 gene is non-essential for virus growth.
Comparison of the growth rate of rpOka∆58 and recombinant wild-type virus by assessing plaque
sizes revealed no significant differences between them both in MRC-5 cells and malignant
melanoma cells.
Conclusion: This study shows that the ORF58 gene is dispensable for viral replication and does
not affect the virus' ability to form plaques in vitro.
Background
Varicella-zoster virus (VZV) is a member of the herpesviri-
dae family, and its primary infection causes varicella in
children. VZV often persistently infects dorsal root ganglia
(DRG) and is sometimes activated from a latent to lytic
state, causing zoster in aged and immunosuppressed indi-
viduals [1]. The double-stranded VZV genome contains
approximately 125 kbp with at least 71 open reading
flames (ORFs) [2]. Although understanding VZV virulence
and attenuation mechanisms requires study of the VZV-
encoded genes, little has been reported on VZV genes
compared with those of herpes simplex virus (HSV).
The ORF58 of VZV lies at the 3'end of the Unique long
(UL) region and its function is unknown. Although
ORF57, its neighboring gene, is dispensable in cell culture
[3], there has been no report yet on ORF58. Therefore, to
investigate the functional roles of this gene in VZV infec-
tion, we constructed an ORF58-deletion mutant of VZV,
and analyzed its susceptibility in both MRC-5 cells and
malignant melanoma cells.
Results and Discussion
We produced the deletion mutant of the ORF58 gene by
using the BAC system [4]. The deletion mutant of the
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ORF58 gene (pOka-BAC∆58) was constructed by recom-
bination in E. coli harboring pOka-BAC DNA [5] and
pGETrec [6] with a fragment containing the kanamycin-
resistance gene flanked by the 3'-UTR and 5'-UTR of the
ORF58 gene. The pGETrec was kindly provided by Dr.
Panayiotis A Ioannou. Thus, the ORF58 gene in the pOKa-
BAC genome was replaced by the kanamycin-resistance
gene (Fig. 1A, B, and 1C).
The recombination was confirmed by Southern blotting
using a fragment of the internal sequence of the ORF58
gene, the ORF62/71 gene, or the kanamycin-resistance
gene as a probe (Fig. 2). As shown in Figure 2, the signal
for the ORF 58 gene was detected in the pOka-BAC
genome but not in the pOka-BAC∆58 genome. The signal
for the ORF62/71 gene, used as a positive control, was
detected in both genomes, and the signal for the kanamy-
cin-resistance gene was detected in the pOka-BAC∆58
genome but not in the pOka-BAC genome. The recombi-
nation was also confirmed by PCR using primer pairs that
annealed to the internal region of the kanamycin-resist-
ance gene and the external region of ORF58 (data not
shown). The results confirmed that the ORF58 gene was
properly replaced by the kanamycin-resistant gene in the
pOka genome.
We next examined whether the ORF58 gene was essential
for the replication of VZV in MRC-5 cells. To reconstitute
the virus from its genome, MRC-5 cells were transfected
with pOka-BAC or pOka-BAC∆58 DNA (Fig. 3). At 4 days
post-transfection, typical cytopathic effects (CPEs), which
fluoresce under the exciting light, was observed in the
Construction of recombinant virus rpOka∆58 Figure 1
Construction of recombinant virus rpOka∆58. (A) The VZV genome consists of two unique regions (UL and US) and of 
inverted repeat sequences (IRL, IRS, and TRSs) flanking the US region. An enlarged section shows the analyzed portion of the 
genome, containing open reading frame (ORF) 56, 57, 58 and 59. ORFs are drawn as pointed rectangles. (B) A fragment con-
sisting of the 3'UTR of ORF58, the kanamycin-resistance gene (kmr), and the 5'UTR of ORF58 was amplified by PCR and used 
for mutagenesis of an infectious full-length pOka genome in E. coli and named Kmr∆58. (C) The entire ORF58 gene was 
replaced by the kanamycin-resistance gene in E. coli. TRL, terminal repeat long; UL, unique long; IRL, internal repeat long; IRS, 
internal repeat short; Us, unique short; TRS, terminal repeat long.
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MRC-5 cells transfected with the pOka-BAC∆58 DNA, as
well as with the pOka-BAC DNA (Fig. 3), suggesting that
the ORF58 gene is dispensable for viral replication in cell
culture.
Before performing the remaining experiments, in order to
exclude the possibility to affect the packaging of viral
genome, we deleted the BAC sequences from the recom-
binant viruses derived from pOka-BAC and pOka-
BAC∆58 using the Cre-loxP system [7] (data not shown),
and the resulting viruses were named rpOka and
rpOka∆58, respectively.
Next, to confirm that rpOka∆58-infected cells did not
express the ORF58 gene, we performed RT-PCR using the
cDNA from rpOka- and rpOka∆58-infected MRC-5 cells
as a template. As shown in Figure 4, ORF58 cDNA was
amplified from the rpOka-infected cells, but not from the
pOka∆58-infected cells, indicating that the ORF58 gene
product was not expressed in the rpOka∆58-infected cells.
As positive controls, the ORF62/71 and GAPDH cDNAs
were both amplified in both types of infected cells (Fig. 4).
Since the deletion mutant rpOka∆58 was able to be recon-
stituted, we next analyzed its ability to form plaques of
rpOka∆58 with that of rpOka. Cell-free rpOka or
rpOka∆58 virus was used to infect MRC-5 cells at approx-
imately 50 PFU/well, and the resulting plaque sizes were
compared (Fig. 5) at 10 days post infection (pi), after the
infected cells were fixed and stained. As shown in Figure
5, no significant difference was observed between the
plaque sizes resulting from infection with the two viruses
(p > 0.05, Student's t-test).
In order to confirm whether rpOka∆58 grow in another
cell lines, human malignant melanoma cell line, MeWo
cells, were infected with these viruses. As shown in Figure
6, no significant difference of their plaque sizes was
observed between the two viruses (p > 0.05, Student's t-
test), suggesting that the ORF58 gene of VZV genome is
dispensable for viral replication and does not affect virus
growth in both cells. These results suggesting that the
ORF58 gene of VZV genome is dispensable for viral repli-
cation and does not affect virus growth in vitro.
Southern blotting analysis of pOka-BAC and pOka-BAC∆58. DNA Figure 2
Southern blotting analysis of pOka-BAC and pOka-BAC∆58. DNA. Purified pOka-BAC DNA and pOka-BAC∆58 
DNA were digested by BamHI and loaded onto a 0.5% TBE agarose gel. The fragments recognized by the ORF58, ORF62/71 
and Kmr probes (right) are indicated by arrowheads in the photograph (left). Southern blotting was performed using ORF58, 
ORF62/71, or the Kmr gene as a probe.
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We have succeeded in deleting the entire ORF58 gene
from the VZV genome using the BAC system. Infectious
viruses could be reconstituted from the ORF58 deletion
mutant, and the reconstituted viruses had similar growth
kinetics to wild-type VZV in cell culture.
In this study, the N terminus of ORF57 was deleted in the
process of deleting ORF58, because the C terminus of
ORF58 overlaps with the N terminus of ORF57. The
ORF57 gene product has been shown to be expressed in
the cytosol and to be dispensable for viral growth in cell
culture [3]. Therefore, we were not concerned that any
observed effects would reflect the loss of the ORF57 N-ter-
minus.
In investigations of VZV ORFs, the SCID-hu system has
been used to assess the in vivo growth and tropism of VZV
mutants constructed in cosmid systems [8-17] and BAC
[18].
In HSV-1 and HSV-2, UL3 is the positional homologue of
ORF58. The UL3 gene product is a phosphoprotein that is
localized to the cytoplasmic and nuclear portions of HSV-
1-infected cells [19]. In HSV-2-infected cells, the UL3 gene
product localizes to the nucleus at the early stage of infec-
tion [20]. Whether the ORF58 gene product possesses
similar characteristics to UL3 remains unknown. Further
study will be required to demonstrate the localization and
possible role of the ORF58 gene product in VZV infection.
Conclusion
Here we show that the ORF58 gene is dispensable for viral
replication and that the deletion mutant, rpOka∆58,
grows as same as wild-type VZV in both MRC-5 cells and
malignant melanoma cells. Construction and investiga-
tion of deletion mutants utilizing BAC system will make it
easier to understand the virulence and attenuation mech-
anisms of VZV.
Methods
Cells and viruses
MRC-5 cells were cultured with modified minimum
essential medium (MEM) supplemented with 10% fetal
bovine serum (FBS). MeWo cells were cultured with Dul-
becco's modified eagle medium (DMEM) supplemented
with 10% FBS. pOka possessing BAC sequence were
obtained previously[5]. Recombinant VZV was propa-
Reconstitution of the infectious recombinant virus Figure 3
Reconstitution of the infectious recombinant virus. (A) MRC-5 cells were transfected with purified pOka-BAC DNA or 
pOka-BAC∆58 DNA. Four days after transfection, typical CPEs, which fluoresce under the exciting light, were observed in the 
cells transfected with either pOka-BAC DNA or pOka-BAC∆58 DNA.
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gated by inoculation of MRC-5 cells with virus-infected
cells.
Generation of virus deletion mutants
VZV ORF58 was deleted within Escherichia coli (E. coli) by
homologous recombination using ET recombinase.
pOka-BAC clone which containing pOka full genome was
generating as described previously [5].
E. coli harboring pOka-BAC DNA was transformed by
pGETrec plasmid which express ET recombinase(kindly
provided by Dr. Panayiotis A Ioannou, Murdoch Chil-
dren's Research Institute, Department of Pediatrics, The
University of Melbourne, Royal Children's Hospital)
using MicroPulser electroporator(BIO-RAD).
To introduce homologous recombination, PCR reaction
was performed in order to generate [flanking-kanamy-
cinR-flanking] fragment using pCRII-TOPO plasmid (Inv-
itrogen) as template. Primer pairs were designed as
follows ; Forward
primer(ACAAATTTCTGATGTTCCCCCGGCGTGGCAAC
GCTGGCATTTCCAAACACAGAAGTTCCTATTCTCTAGA
AAGTATAGGAACTTCAGCAAGCGAACCGGA  ATTGC)
contains homologous sequence of the upstream of
ORF58(ACAAATTTCTGATGTTCCCCCGGCGT-
GGCAACGCTGGCATTTCCAAACACA) as flanking
sequence, FRT sequence(GAAGTTCCTATTCTCTA-
GAAAGTATAGGAACTTC, single under line), homolo-
gous sequence of kanamycin resistant gene within pCRII-
TOPO plasmid(AGCAAGCGAACCGGAATTGC, double
under line). Reverse primer
(GATCGATTGGAGTGTTATATAACACTCCAATCGACCCT
CTCGCGTACCATGAAGTTCCTATACTTTCTAGAGAAT-
AGGAACTTCCTTTTTCAATTCAGAAGAACTC) contains
homologous sequence of the downstream of ORF58
(GATCGATTGGAGTGTTATATAACACTCCAATCGAC-
CCTCTCGCGTACCAT) as flanking sequence, FRT
sequence (GAAGTTCCTATACTTTCTAGAGAATAG-
GAACTTC, single under line), homologous sequence of
kanamycin resistant gene within pCRII-TOPO plasmid
(CTTTTTCAATTCAGAAGAACTC, double under line).
PCR products were transformed into E. coli harboring
pOka-BAC DNA and pGETrec plasmid. The recombined
clones were selected by chloramphenicol/kanamycin on
LB plates and the correct recombination was confirmed by
PCR (data not shown).
Preparation of pOka-BAC and pOka-BAC∆58 genome
pOka-BAC and pOka-BAC∆58 genome was isolated using
a NucleoBond BAC 100 kit (Macherey-Nagel) following
the manufacturer's protocol.
Confirming the expression of ORF58 by RT-PCR Figure 4
Confirming the expression of ORF58 by RT-PCR. rpOka or rpOka∆58-infected cells were harvested at 24 hrs p.i., and 
the RNAs were extracted. The cDNAs were synthesized from each RNA using Superscript III (Invitrogen), and PCRs were 
performed using the cDNAs as templates. PCRs were also performed with RT(-) to avoid amplification of contaminating 
genomic DNA. The size of each product is indicated by an arrow at the right of each panel. The molecular size (bp) is shown 
on the left of each panel. N.C.: negative control.
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Reconstitution of infectious virus
One  µg of pOka-BAC or pOka-BAC∆58 genome was
transfected into MRC-5 cells by electroporation using a
Nucleofection unit (Amaxa biosystems). The cells were
then cultured with MEM supplement with 10% FBS for 4
days. To remove BAC sequence, MRC-5 cells were first
infected with a recombinant adenovirus, AxCANCre,
which expresses the Cre recombinase (kindly provided by
Dr. Yasushi Kawaguchi, University of Tokyo). Twenty-four
hrs later, the cells were super-infected with the recom-
binant viruses obtained from pOka-BAC genome(rpOka-
BAC) or pOka-BAC∆58 genome(rpOka-BAC∆58), and
cultured until plaques without GFP appeared. The plaques
without GFP were isolated using glass isolation cups and
transferred onto newly prepared MRC-5 cells to obtain
BAC-deleted viruses, rpOka or rpOka∆58. After several
rounds of isolation, cell-free viruses were obtained by son-
icating the rpOka or rpOka∆58-infected cells and stored at
-80°C.
Southern blotting
Genome DNA of pOka-BAC and rpOka∆58 were
extracted from E. coli. One µg of both DNAs were digested
with BamHI and loaded onto 0.5% agarose gel and elec-
trophoresis was performed in 0.5 × TBE (44.5 mM Tris,
44.5 mM Borate, 1 mM EDTA). At 72 hour later, DNA
fragments were transferred to Hybond N+ nylon mem-
brane(GE healthcare) with 0.4 N NaOH followed by
washing with 2 × SSC (300 mM NaCl, 30 mM Na3-cit-
rate). Hybridization and detection were performed using
Plaque size comparison between rpOka and rpOka∆58 in MRC-5 cells Figure 5
Plaque size comparison between rpOka and rpOka∆58 in MRC-5 cells. Plaque sizes after infection with cell-free 
rpOka and rpOka∆58 are indicated graphically (upper) and in photographs (lower). MRC-5 cells were infected with each cell-
free virus and cultured for 10 days. The cells were fixed and stained with 1% crystal violet/70% EtOH and the sizes of 38 
plaques (rpOka) and 41 plaques (rpOka∆58) were calculated and analyzed using ImageJ software (NIH, USA). Error bars in the 
graph indicate the standard deviation (SD).Virology Journal 2008, 5:54 http://www.virologyj.com/content/5/1/54
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ECL direct labeling and detection system (GE healthcare).
Probes used to detect ORF58, ORF62 and kanamycin
resistant gene were labeled using the system following
manufacture's protocol. The primer pairs used to create
probes were: ORF58, VZ58F (aggacacgatctaaagccgt) and
VZ58R (tccgtaccgacggcattgct); ORF62/71, G62N4 (gat-
caaagcttagcgcag) and G62R4 (cctatagcatggctccag); kan-
amycin-resistance gene, KMF (atgattgaacaagatggattg) and
KMR (aagaaggcgatagaaggcgatg). The transferred mem-
brane was treated with hybridization buffer for 2 hours at
42°C followed by hybridization with the labeled probes
for 18 hours at 42°C following manufacture's protocol,
then was washed with primary wash buffer (6 M urea,
0.4% SDS and 0.5 × SSC) for 4 times at 42°C followed by
washing with secondary wash buffer (2 × SSC), and the
Plaque size comparison between rpOka and rpOka∆58 in MeWo cells Figure 6
Plaque size comparison between rpOka and rpOka∆58 in MeWo cells. Plaque sizes after infection with cell-free 
rpOka and rpOka∆58 are indicated graphically (upper) and in photographs (lower). MeWo cells were infected with each cell-
free virus and cultured for 10 days. The cells were fixed and stained with 1% crystal violet/70% EtOH and the sizes of 282 
plaques (rpOka) and 208 plaques (rpOka∆58) were calculated and analyzed using ImageJ software (NIH, USA). Error bars in 
the graph indicate the standard deviation (SD).
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signals were detected with ECL detection reagents (GE
healthcare) followed by exposing to X-ray film.
RT-PCR
rpOka or rpOka∆58-infected cells were harvested at 24
hours p.i. Cells were extracted with 1 mL of TRIzol Rea-
gent (Invitrogen) and 200 µL of chloroform. Cell extract
was centrifuge and supernatant was added with 500 µL of
isopropanol. Nucleic acid containing total RNA was
obtained by centrifuge and resolved with 20 µL of DEPC-
treated water. Seven µL of solution was added with 2 µL of
10× DNase buffer and 1 µL of DNaseI and incubated for
20 minutes followed by added with 1 µL of 25 mM EDTA
and incubated at 60°C for 20 minutes thereafter trans-
ferred on ice. Eight micro litters of solution was added
with 1 µL of oligo(dT)15 and 4 µL of dNTP(2.5 mM each)
and incubated at 65°C for 5 minutes thereafter incubated
on ice for 5 minutes. Solution was then added with 4 µL
of 5× buffer, 1 µL of 0.1 M DTT, 1 µL of RNase inhibitor
and 1 µL of SuperScriptIII reverse transcriptase(Invitro-
gen) and incubated at 50°C for 60 minutes followed by
incubated at 70°C for 15 minutes. Single stranded RNA
was digested from DNA/RNA hybrid by adding 0.5 µL of
RNaseH and incubated at 37°C for 20 minutes.
Expression of mRNAs were confirmed using primers set
anneal to ORF58 (forward primer: VZ58F (aggacac-
gatctaaagccgt), reverse primer: VZ58R (tccgtaccgacggcatt-
gct)), ORF62 (forward primer: G62N4
(gatcaaagcttagcgcag), reverse primer: G62R4 (cctatagcat-
ggctccag)) and GAPDH (forward primer: G3PDHF
(accacagtccatgccatcac), reverse primer: G3PDHR (tccac-
caccctgttgctgta)). pOka-BAC DNA was used as positive
control.
Comparison of Plaque sizes
VZV recombinants were assessed for the property of cell-
to-cell spread by comparison of plaque sizes. Briefly,
MRC-5 cells or MeWo cells were infected with approxi-
mately 50 PFU of cell-free viruses of rpOka or rpOka∆58,
which was produced from pOka-BAC or pOka-BAC∆58
genome. The cells were cultured for 7 days at 37°C fol-
lowed by stained with 1% crystal violet/70% ethanol.
Plaque sizes were calculated with ImageJ software (NIH,
USA).
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